Skip to content

Gross margin at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
46.8%+2.5pp
TFX
TeleflexTFX
38.2%-3.0pp
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
65.5%-1.6pp
IAR
Integra LifeSciencesIART
51.9%-1.6pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
48.7%+0.9pp
PDE
Pro-Dex, Inc.PDEX
27.8%-3.6pp

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity
Current ratio28.6×+6.3×

Where this comes from

Calculated from Utah Medical Products’s reported figures.

Based on trailing twelve months.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's gross margin?
Utah Medical Products (UTMD) reported gross margin of 57.9% in Q1 2026.
How has Utah Medical Products's gross margin changed year-over-year?
Utah Medical Products's gross margin decreased by 0.7% year-over-year, from 58.4% to 57.9%.
What is the long-term trend for Utah Medical Products's gross margin?
Over 5 years (2020 to 2025), Utah Medical Products's gross margin has grown at a -1.2% compound annual growth rate (CAGR), from 60.6% to 57.1%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.